<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117530">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01717469</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 00610412.2.0000.0068</org_study_id>
    <nct_id>NCT01717469</nct_id>
  </id_info>
  <brief_title>Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias</brief_title>
  <acronym>SAFE-LVPACE</acronym>
  <official_title>Randomized Clinical Study to Assess the Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous experimental and clinical studies have consistently suggested that right
      ventricular (RV) apical pacing has important adverse effects. Ventricular pacing, however,
      is required, and cannot be reduced in many patients with atrioventricular block. The
      SAFE-LVPACE study is a randomized controlled trial that compare the effects of conventional
      right ventricular (RV) pacing vs. left ventricular (LV) in patients with AV block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the past several years, there has been growing concern over the significant deleterious
      effects of RV pacing, including electromechanical dyssynchrony, proarrhythmia and
      development of heart failure (HF). However, it remains unclear whether pacing-related
      ventricular dyssynchrony can translate into significant LV structural changes and produce
      important clinical impairment in an average pacemaker population with compromised AV
      conduction. Alternatively, left ventricular pacing has been shown to minimize ventricular
      dyssynchrony and to improve symptoms and prognosis in patients with mild to moderated
      systolic HF and prolonged QRS duration.

      This randomized controlled study is been conducted to compare the effects of conventional
      right ventricular (RV) pacing vs. left ventricular (LV) in patients with AV block. The
      hypothesis is that isolated LV pacing through the coronary sinus can be used safely and
      provide greater hemodynamic benefits to patients with AV block and normal ventricular
      function who require only the correction of heart rate.

      Specifically, the investigator aims are to evaluate the safety, efficacy and the effects of
      left ventricular pacing using active-fixation coronary sinus lead—the Attain StarFix® Model
      4195 OTW Lead, compared to right ventricular pacing in patients with implantation criteria
      for conventional pacemaker stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Surgical success</measure>
    <time_frame>Participants will be evaluated during the perioperative period and during the hospital stay, an expected average of 2 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Surgical success: absence of complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic and Clinical composite</measure>
    <time_frame>Participants will be evaluated at 6 and 24 months after PM implantation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Echocardiographic: ventricular dysfunction Clinical composite: all mortality, cardiovascular mortality, hospitalization, heart failure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Participants will be evaluated at 6 and 24 months after PM implantation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of life: improvement on quality of life scores measured by three questionnaires: 36-Item Short Form Health Survey (SF-36), a disease specific questionnaire for pacemaker patients (Aquarel) and Minnesota Living With Heart Failure (MLWHF).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Bradyarrhythmias</condition>
  <condition>Arrhythmias</condition>
  <condition>Atrioventricular Block</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>RV Pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Right ventricular pacing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LV Pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left ventricular pacing through coronary sinus tributaries</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Left ventricular pacing through coronary sinus tributaries (Attain StarFix)</intervention_name>
    <description>Left ventricular pacing in patients with bradycardia</description>
    <arm_group_label>LV Pacing</arm_group_label>
    <other_name>Attain StarFix® Model 4195 OTW Lead</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Right ventricular pacing (Medtronic)</intervention_name>
    <description>Conventional right ventricular pacing in patients with bradycardia.</description>
    <arm_group_label>RV Pacing</arm_group_label>
    <other_name>Right ventricular lead Medtronic 5076-58</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 18 years

          -  Pacemaker initial implant by transvenous approach

          -  Presence of AV block

          -  Presence of atrial fibrillation / atrial flutter with slow ventricular response

          -  Left ventricular systolic function &gt; 0.40

          -  Subject agreed to participate and signed the consent form

        Exclusion Criteria:

          -  Absence of venous access

          -  Impediment of venous access due to presence of intracardiac defects

          -  Impediment of venous access due to presence of tricuspid valve prosthesis

          -  Need for radiotherapy in the chest

          -  Presence of chest deformity

          -  Pregnancy

          -  Life expectancy of less than one year

          -  Contraindication to administration of iodinated contrast (creatinine &gt; 3.0) Unable to
             attend the follow-up appointments
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto Costa, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberto Costa, MD PhD</last_name>
    <phone>55-11-2661</phone>
    <phone_ext>5284</phone_ext>
    <email>rcosta@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katia R Silva, RN PhD</last_name>
    <phone>9195978619</phone>
    <email>katia.research@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robeto Costa, MD PhD</last_name>
      <phone>55-11-2661</phone>
      <phone_ext>5284</phone_ext>
      <email>rcosta@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Katia R Silva, RN PhD</last_name>
      <phone>9195978619</phone>
      <email>katia.research@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Roberto Costa, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth S Crevelari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katia R Silva, RN, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caio MM Albertini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marianna S Lacerda, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martino Martinelli Filho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wagner T Tamaki, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto M Oliveira Jr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wilson Mathias Jr, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvana AD Nishioka, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irapuan M Penteado, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 5, 2012</lastchanged_date>
  <firstreceived_date>September 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Roberto Costa</investigator_full_name>
    <investigator_title>Associated Professor of Cardiovascular Surgery, MD PhD</investigator_title>
  </responsible_party>
  <keyword>Pacemaker</keyword>
  <keyword>Pacemaker implantation</keyword>
  <keyword>Coronary sinus</keyword>
  <keyword>Ventricular dysfunction</keyword>
  <keyword>Right ventricular pacing</keyword>
  <keyword>Left ventricular pacing</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Atrioventricular Block</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
